While natural adenoviruses primarily infect CAR receptor-positive cells through fibronectin binding, genetically engineered OAds are capable of precisely targeting CAR-negative tumor cells, thereby reducing the risk of infecting normal tissues. The gene discussed is FN1; the disease is neoplasm.